BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

1:28 PM
 | 
Jul 31, 2019
 |  BC Extra  |  Company News

Apelian to lead new T cell company BlueSphere

Editor's Note: This article was updated on Aug 01, 2019 at 10:19 AM PDT

With serial biotech executive David Apelian as CEO, University of Pittsburgh and UPMC spinout BlueSphere debuted Wednesday with plans to move its personalized T cell therapies into the clinic.

Pitt professors Mark and Warren Shlomchik, who are brothers, co-founded BlueSphere Bio (Pittsburgh, Pa.) in 2017 based on their TCXpress platform,...

Read the full 229 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >